We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.05%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$101B
AUM Growth
+$37.4B
(+59%)
Cap. Flow
+$36.7B
Cap. Flow
% of AUM
36.22%
Top 10 Holdings %
Top 10 Hldgs %
21.17%
Holding
5,633
New
1,585
Increased
2,056
Reduced
1,281
Closed
669
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
NVIDIA
NVDA
|
+$1.29B |
| 3 |
Apple
AAPL
|
+$690M |
| 4 |
Microsoft
MSFT
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.67B |
| 2 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$204M |
| 3 |
SPDR Gold Trust
GLD
|
+$173M |
| 4 |
Costco
COST
|
+$161M |
| 5 |
Qualcomm
QCOM
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.66% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Financials | 3.61% |
| 4 | Healthcare | 3.25% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4601
Sabre
SABR
$656M
| $135K | ﹤0.01% |
36,872
+20,163
| +121% | +$73.9K |
|
4602
Milestone Pharmaceuticals
MIST
$144M
| $134K | ﹤0.01% |
56,751
+2,506
| +5% | +$4.3K |
|
|
PSTX
4603
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $134K | ﹤0.01% |
13,950
-98,315
| -88% | -$513K |
|
4604
Hillman Solutions
HLMN
$1.56B
| $134K | ﹤0.01% |
+13,709
| New | +$147K |
|
4605
Clear Channel Outdoor Holdings
CCO
$1.23B
| $133K | ﹤0.01% |
96,955
-255,033
| -72% | -$390K |
|
|
VNET
4606
VNET Group
VNET
$2.05B
| $132K | ﹤0.01% |
+27,933
| New | +$106K |
|
4607
Pediatrix Medical
MD
$2.16B
| $132K | ﹤0.01% |
+10,049
| New | +$139K |
|
4608
Humacyte
HUMA
$168M
| $132K | ﹤0.01% |
+26,098
| New | +$129K |
|
4609
Oramed Pharmaceuticals
ORMP
$165M
| $132K | ﹤0.01% |
54,439
-28,916
| -35% | -$68.7K |
|
4610
Duluth Holdings
DLTH
$160M
| $131K | ﹤0.01% |
42,494
-26,001
| -38% | -$94.5K |
|
4611
Kaltura
KLTR
$211M
| $131K | ﹤0.01% |
59,415
+38,854
| +189% | +$70.9K |
|
4612
PUT
Vermilion Energy
VET
$1.73B
| $131K | ﹤0.01% |
+13,900
| New | +$135K |
|
4613
LXP Industrial Trust
LXP
$3.53B
| $130K | ﹤0.01% |
3,210
-11,809
| -79% | -$547K |
|
4614
Nektar Therapeutics
NKTR
$2.39B
| $130K | ﹤0.01% |
+9,317
| New | +$164K |
|
|
CMRX
4615
DELISTED
Chimerix, Inc.
CMRX
| $130K | ﹤0.01% |
+37,297
| New | +$52.6K |
|
4616
CALL
TMC The Metals Company
TMC
$1.59B
| $129K | ﹤0.01% |
+115,600
| New | +$109K |
|
|
BORR
4617
PUT
Borr Drilling
BORR
$1.31B
| $129K | ﹤0.01% |
+33,100
| New | +$141K |
|
4618
PUT
EVgo
EVGO
$200M
| $129K | ﹤0.01% |
+31,800
| New | +$202K |
|
|
BGFV
4619
DELISTED
Big 5 Sporting Goods
BGFV
| $128K | ﹤0.01% |
71,627
+56,971
| +389% | +$104K |
|
4620
CALL
Weibo
WB
$1.9B
| $128K | ﹤0.01% |
+13,400
| New | +$128K |
|
4621
PUT
The RealReal
REAL
$1.34B
| $128K | ﹤0.01% |
+11,700
| New | +$62.2K |
|
|
FLNA
4622
Filana Therapeutics
FLNA
$43M
| $128K | ﹤0.01% |
54,090
+43,757
| +423% | +$768K |
|
4623
Domo
DOMO
$166M
| $127K | ﹤0.01% |
+17,872
| New | +$145K |
|
4624
Erasca
ERAS
$6.63B
| $126K | ﹤0.01% |
+50,308
| New | +$138K |
|
4625
Westwater Resources
WWR
$51M
| $126K | ﹤0.01% |
177,965
+41,515
| +30% | +$23.9K |
|
Similar funds
Squarepoint's Q4 2024 Portfolio in Review
As of Q4 2024, Squarepoint held 5,633 positions worth $101B, up 59% from $63.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint deployed $36.7B of net new capital in Q4 2024, opening 1,585 new positions and adding to 2,056 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $2.67B trimmed.
- Squarepoint's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
- Squarepoint added most to NVIDIA in Q4 2024, an estimated $1.29B increase.
- Squarepoint's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.67B.
- Squarepoint fully exited State Street Financial Select Sector SPDR ETF in Q4 2024, selling an estimated $86.3M.
- Squarepoint's ten largest holdings make up 21% of its $101B portfolio in Q4 2024.
- Squarepoint opened 1,585 new positions and closed 669 in Q4 2024.
- Squarepoint's portfolio value rose 59% quarter-over-quarter to $101B.
Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.